HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Keiji Wakabayashi Selected Research

3,4,11- trihydroxy- 2- (hydroxymethyl)- 8- (4- hydroxyphenyl)- 3,4,4a,11b- tetrahydro- 2H,10H- pyrano(2',3'- 4,5)furo(3,2- g)chromen- 10- one

4/2006Inhibition of intestinal carcinogenesis by a new flavone derivative, chafuroside, in oolong tea.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD

Keiji Wakabayashi Research Topics

Disease

34Neoplasms (Cancer)
07/2010 - 01/2002
20Colonic Neoplasms (Colon Cancer)
08/2007 - 01/2002
13Intestinal Polyps
12/2009 - 09/2002
12Adenocarcinoma
08/2008 - 04/2003
7Hyperlipidemias (Hyperlipidemia)
10/2007 - 09/2003
6Polyps
12/2009 - 09/2002
6Carcinoma (Carcinomatosis)
10/2006 - 01/2003
5Body Weight (Weight, Body)
07/2010 - 06/2005
4Adenoma (Adenomas)
03/2008 - 06/2004
4Inflammation
08/2007 - 06/2004
3Pancreatic Neoplasms (Pancreatic Cancer)
07/2010 - 08/2007
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2009 - 03/2006
3Colitis
08/2007 - 01/2006
3Adenomatous Polyposis Coli (Familial Adenomatous Polyposis)
04/2004 - 07/2003
3Gastritis
10/2003 - 02/2002
2Lung Neoplasms (Lung Cancer)
01/2009 - 02/2008
2Colorectal Neoplasms (Colorectal Cancer)
12/2008 - 03/2006
2Tongue Neoplasms (Tongue Neoplasm)
03/2007 - 03/2006
1Papilloma (Papillomatosis)
03/2009
1DNA Damage
12/2008
1Duodenogastric Reflux
09/2008
1Hypertriglyceridemia
04/2008
1Type 2 Diabetes Mellitus (MODY)
10/2007
1Diabetes Mellitus
10/2007
1Chronic Hepatitis C
10/2006
1Hyperplasia
05/2006

Drug/Important Bio-Agent (IBA)

7Messenger RNA (mRNA)IBA
12/2009 - 01/2002
7Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
08/2008 - 03/2002
7beta CateninIBA
10/2007 - 06/2004
5pioglitazone (Actos)FDA Link
08/2007 - 09/2003
5PPAR gammaIBA
08/2007 - 09/2003
5Prostaglandins E (PGE)IBA
03/2007 - 01/2002
5nimesulide (Aulin)IBA
03/2006 - 01/2002
4Triglycerides (Triacylglycerol)IBA
03/2009 - 09/2003
4Cyclooxygenase 2 (Cyclooxygenase-2)IBA
03/2008 - 04/2004
4sodium sulfate (sodium bisulfate)FDA LinkGeneric
10/2007 - 01/2005
4PPAR alphaIBA
10/2007 - 09/2003
4Dextrans (Dextran)FDA Link
10/2007 - 01/2005
4AzoxymethaneIBA
10/2006 - 02/2005
4Prostaglandin E Receptors (Prostaglandin E Receptor)IBA
12/2005 - 07/2003
3nitrosobis(2-oxopropyl)amine (NBOP)IBA
07/2010 - 08/2007
3Lipoprotein Lipase (Diacylglycerol Lipase)IBA
12/2009 - 02/2005
37- chloro- 3- imino- 5- methyl- 2- azabicyclo(4.1.0)heptaneIBA
08/2008 - 03/2006
3Codon (Codons)IBA
02/2008 - 06/2004
3DNA (Deoxyribonucleic Acid)IBA
10/2007 - 11/2004
3Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
10/2007 - 04/2004
3ONO 8711IBA
03/2007 - 07/2003
3mofezolac (N 22)IBA
10/2006 - 09/2002
32- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA
06/2005 - 01/2002
3CarcinogensIBA
04/2004 - 10/2002
2Biological Markers (Surrogate Marker)IBA
12/2008 - 03/2006
2Urethane (Ethyl Carbamate)IBA
09/2008 - 02/2008
2Proteins (Proteins, Gene)IBA
02/2008 - 01/2005
29- (4'- aminophenyl)- 9H- pyrido(3,4- b)indoleIBA
10/2007 - 03/2002
2Indomethacin (Indometacin)FDA LinkGeneric
10/2007 - 04/2004
2LipidsIBA
10/2007 - 03/2003
2Cyclooxygenase 1IBA
10/2006 - 04/2004
2BezafibrateIBA
04/2006 - 09/2003
24- diethoxyphosphorylmethyl- N- (4- bromo- 2- cyanophenyl)benzamideIBA
04/2006 - 02/2005
2ProstaglandinsIBA
01/2006 - 06/2004
2Bromodeoxyuridine (BrdU)IBA
05/2005 - 05/2003
2Nitric Oxide (Nitrogen Monoxide)FDA Link
06/2004 - 10/2003
1Contrast MediaIBA
07/2010
1Iopamidol (Isovue)FDA LinkGeneric
07/2010
1Scopolamine (Hyoscine)FDA Link
07/2010
1butyl bromideIBA
07/2010
1LDL Receptors (LDL Receptor)IBA
12/2009
1oil red OIBA
12/2009
1anthraceneIBA
03/2009
19,10-Dimethyl-1,2-benzanthracene (DMBA)IBA
03/2009
1KaolinIBA
01/2009
1Arachidonic Acid (Vitamin F)IBA
12/2008
1Oleic AcidsIBA
12/2008
1Fatty Acids (Saturated Fatty Acids)IBA
12/2008
1Arachidonic AcidsIBA
12/2008
1Linoleic Acid (Linoleate)IBA
12/2008
1Vitellogenins (Vitellogenin)IBA
12/2008
1DNA AdductsIBA
09/2008
1O(6)-(carboxymethyl)-2'-deoxyguanosineIBA
09/2008
13-ethanesulfonic acid 2'-deoxycytidineIBA
09/2008
1salicylhydroxamic acid (SHAM)IBA
09/2008
1NucleotidesIBA
09/2008
1thiazolidine-4-carboxylic acidIBA
09/2008
1AdipokinesIBA
04/2008
1Plasminogen Activators (Plasminogen Activator)IBA
04/2008
1Plasminogen Activator Inhibitor 1IBA
04/2008
1Reactive Oxygen Species (Oxygen Radicals)IBA
02/2008
1Epidermal Growth Factor Receptor (EGF Receptor)IBA
02/2008
11,2-diacylglycerolIBA
06/2007
1Protein Kinase CIBA
06/2007
1Ursodeoxycholic Acid (Urso)FDA LinkGeneric
04/2007
1Sulfasalazine (Azulfidine)FDA LinkGeneric
04/2007
1LactoferrinIBA
10/2006
1RNA (Ribonucleic Acid)IBA
10/2006
1milk-derived factorIBA
10/2006
1coenzyme Q10 (CoQ10)IBA
10/2006
1SulfadimethoxineIBA
05/2006
1SDMIBA
05/2006

Therapy/Procedure

4Chemoprevention
03/2006 - 04/2004
1Subcutaneous Injections
10/2006